Keyphrases
BCP-ALL
64%
Hox Genes
48%
Cdx Genes
45%
Posterior Growth Zone
33%
Paediatric B-cell Precursor Acute Lymphoblastic Leukaemia
25%
TCF3-PBX1
24%
BCR-ABL1
24%
Morphogenesis
24%
Trunk
24%
Wnt Signaling
24%
Leukemic Cells
23%
Primary B Cells
22%
Mesenchymal Stromal Cells
22%
Acute Lymphoblastic Leukemia Cells
22%
Cell Tumor
20%
Cloacal
19%
Axial Growth
19%
Tyrosine Kinase Inhibitor Resistance
19%
Kinase Domain mutations
19%
3D Live Imaging
19%
Cell Behavior
19%
Ibrutinib
19%
Childhood B-cell Precursor Acute Lymphoblastic Leukemia
19%
Engineered T Cells
19%
Aberrations
19%
Mammalian Embryo
19%
Imaging Platform
19%
Bone Marrow Cells
19%
Tumor Response
19%
Treatment Adaptation
19%
Behavioral Response
19%
Predictive Biomarker
19%
Pathway mutation
19%
RAS Pathway
19%
Bone Marrow
19%
Janus Kinase 2 (JAK2)
19%
CDX2
19%
Effective Compounds
19%
Mesenchymal Stroma
19%
Interferon Response
19%
Fibroblast Growth Factor Receptor 1 (FGFR1)
19%
Neural Tube
19%
Evolutionarily Conserved
19%
Secondary Lesions
19%
Truncation
16%
Mouse Embryo
14%
Interferon-α (IFN-α)
13%
Wnt3a
12%
Subclonal mutations
12%
Supporting Cells
12%
Biochemistry, Genetics and Molecular Biology
Precursor
62%
B Cell
62%
Cdx
58%
Hox Gene
40%
Wnt Signaling Pathway
23%
Morphogenesis
23%
Janus Kinase
20%
Neural Tube
19%
Cell Function
19%
T Cell
19%
Tyrosine Kinase Inhibitor
19%
Kinase
19%
Phosphotransferase
19%
Interferon
19%
Chromosome 21
19%
Coculture
18%
Immunocompetent Cell
16%
Trametinib
11%
Imatinib
11%
Transcription Factors
9%
Intravenous Immunoglobulin
9%
Stromal Cell
8%
Gene Expression
8%
Janus Kinase Inhibitor
7%
SH2B3
7%
CRLF2
5%
IKZF1
5%
PAX5
5%
Ruxolitinib
5%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Precursor
85%
B Cell
85%
Janus Kinase
20%
Ibrutinib
19%
Stroma
19%
Interferon
19%
Phosphotransferase
19%
Tyrosine-Kinase Inhibitor
19%
Chromosome 21
19%
Mesenchymal Stem Cell
17%
Leukemia Cell
17%
Ex Vivo
12%
Pediatrics
9%
Janus Kinase Inhibitor
7%
Chemokine
6%
Bone Marrow Microenvironment
5%
Imatinib Resistance
5%
Imatinib
5%
Ruxolitinib
5%
Leukemia
5%